12.05.23 -- Using Automation For Antimicrobial Screening

A 360-degree approach entails full CMC development and analytical release testing in support of biopharmaceutical products in development and in clinical trials — all from one partner.

Conducting solid form screening early can help your team select and isolate the ideal lead polymorph to ensure manufacturability and stability while avoiding costs and hiccups down the road.

A recent project applied process improvement methodology to the process validation step that ultimately provided not only an optimized, robust process but also an economic advantage.

This article discusses key parameters for choosing the right particle engineering approach to meet dry powder inhaler (DPI) target product profiles for inhalation-based drug products.

Cryo electron microscopy can help you determine structures for challenging proteins, such as membrane proteins and larger complexes. This presentation offers tips on purifying your cryo-EM samples.

Cost efficiencies and expertise again go hand in hand, with companies often outsourcing or partnering primarily to gain access to manufacturing know-how.

Lonza principal scientist Deanna Mudie, Ph.D., covers the design of dissolution media to support biopredictive dissolution testing and how the properties of a drug and formulation affect performance.

Gain valuable insights into the jet milling process and quality by design approach for inhalation drug delivery and their potential applications in drug development.